The European antibody network's practical guide to finding and validating suitable antibodies for research
![Frontiers | Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies Frontiers | Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies](https://www.frontiersin.org/files/Articles/585896/fbioe-08-585896-HTML/image_m/fbioe-08-585896-t002.jpg)
Frontiers | Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies
![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics](https://www.mdpi.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g001.png)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F3.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics](https://pub.mdpi-res.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g007.png?1577720962)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F4.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy | PLOS Biology
The European antibody network's practical guide to finding and validating suitable antibodies for research
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F2.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy | PLOS Biology
![An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/21fb6d9c-a47c-4117-b8f0-35192ecdc709/bpa_181_f1.gif)